Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Vitamin C is a powerful antioxidant and its levels are decreased in Alzheimer's patients. Even sub-clinical vitamin C deficiency could impact disease development. To investigate this principle we crossed APP/PSEN1 transgenic mice with Gulo knockout mice unable to synthesize their own vitamin C. Experimental mice were maintained from 6 weeks of age on standard (0.33 g/L) or reduced (0.099 g/L) levels of vitamin C and then assessed for changes in behavior and neuropathology. APP/PSEN1 mice showed impaired spatial learning in the Barnes maze and water maze that was not further impacted by vitamin C level. However, long-term decreased vitamin C levels led to hyperactivity in transgenic mice, with altered locomotor habituation and increased omission errors in the Barnes maze. Decreased vitamin C also led to increased oxidative stress. Transgenic mice were more susceptible to the activity-enhancing effects of scopolamine and low vitamin C attenuated these effects in both genotypes. These data indicate an interaction between the cholinergic system and vitamin C that could be important given the cholinergic degeneration associated with Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Memory: A Contribution to Experimental Psychology
Ebbinghaus, H. (2013) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.200408 · Cited by 2,827
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Dietary Intake of Antioxidants and Risk of Alzheimer Disease
Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744 · cited 1×
“A similar exponential increase begins at 4-5 months of age inAPP/PSEN1double-transgenics (Garcia-Alloza et al., 2006;Gordon et al., 2002).”
BackgroundMorris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678 · cited 1×
“Furthermore, dietary deficiency may be even more dangerous in those carrying genetic risk factors for developing Alzheimer's disease (Morris et al., 2002).”
BackgroundVitamin C function in the brain: Vital role of the ascorbate transporter SVCT2
Harrison, F. E., & May, J. M. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.12.018 · Cited by 661
Self-citationAntioxidant Vitamin Intake and Risk of Alzheimer Disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.203 · Cited by 414 · cited 1×
“Other studies found no such associations (Gray et al., 2008; Laurin et al., 2004; Luchsinger et al., 2003; Paraskevas et al., 1997).”
Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease
Morris, M. C., Beckett, L. A., Scherr, P. A., Hebert, L. E., Bennett, D. A., Field, T. S., & Evans, D. A. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00001 · Cited by 332
Protection and Recycling of α-Tocopherol in Human Erythrocytes by Intracellular Ascorbic Acid
May, J. M., Qu, Z.-C., & Mendiratta, S. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0473 · Cited by 316 · cited 1×
“Vitamin C concentrationsweremeasured by ion pair HPLC (Pachla andKissinger, 1979) andelectrochemical detection aspreviously described (Harrison et al., 2008; May et al., 1998), with tetrapentyl ammonium bromide used as the ion pair reagent.”
MethodSelf-citationAscorbic acid and dehydroascorbic acid measurements in human plasma and serum
Dhariwal, K., Hartzell, W., & Levine, M. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.4.712 · Cited by 262 · cited 1×
“Circulating DHA concentrations in are very low human plasma (b2 μM) relative to those of ascorbate con (40–50 μM) (Dhariwal et al., 1991).”
BackgroundAortic wall damage in mice unable to synthesize ascorbic acid
Maeda, N., Hagihara, H., Nakata, Y., Hiller, S., Wilder, J., & Reddick, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.841 · Cited by 260
Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse
Gordon, M. N., Holcomb, L. A., Jantzen, P. T., DiCarlo, G., Wilcock, D., Boyett, K. W., Connor, K., Melachrino, J., O'Callaghan, J. P., & Morgan, D. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7754 · Cited by 247
Resende, R., Ferreiro, E., Pereira, C., & Resende de Oliveira, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.036 · Cited by 235 · cited 1×
“Both Aβ and oxidative stress are toxic to neurons (Manelli and Puttfarcken, 1995; Resende et al., 2008), and have been shown to impair memory in an acute, drug-like fashion in the absence of Aβ aggregation (McDonald et al., 1994; McDonald et al., 1996; Sweeney et al., 1997).”
BackgroundLaurin, D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh124 · Cited by 231
Lalonde, R., Kim, H. D., Maxwell, J. A., & Fukuchi, K. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.028 · Cited by 170
Elimination of GD3 synthase improves memory and reduces amyloid-β plaque load in transgenic mice
Bernardo, A., Harrison, F. E., McCord, M., Zhao, J., Bruchey, A., Davies, S. S., Jackson Roberts, L., Mathews, P. M., Matsuoka, Y., Ariga, T., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.022 · Cited by 127
Self-citationAntioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older Adults
Gray, S. L., Anderson, M. L., Crane, P. K., Breitner, J. C. S., McCormick, W., Bowen, J. D., Teri, L., & Larson, E. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01531.x · Cited by 127 · cited 1×
“Other studies found no such associations (Gray et al., 2008; Laurin et al., 2004; Luchsinger et al., 2003; Paraskevas et al., 1997).”
Perluigi, M., Joshi, G., Sultana, R., Calabrese, V., De Marco, C., Coccia, R., Cini, C., & Butterfield, D. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20879 · Cited by 125 · cited 1×
“In turn, small Aβ oligomers act at themitochondrion to increase production of reactive oxygen species and induce further oxidative damage (Butterfield et al., 2001;Mark et al., 1996; Pappolla et al., 1998; Perluigi et al., 2006; Uberti et al., 2007).”
BackgroundExploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/ΔE9 mice
Lalonde, R., Kim, H. D., & Fukuchi, K. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.069 · Cited by 121 · cited 2×
“APP/PSEN1 bigenicmice exhibit slightly decreased anxiety in some studies (Lalonde et al., 2004; Reiserer et al., 2007) but not in others (Bernardo et al., 2008).”
BackgroundYang, X., Yang, Y., Li, G., Wang, J., & Yang, E. S. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9033-7 · Cited by 111
Ascorbic acid-independent synthesis of collagen in mice
Parsons, K. K., Maeda, N., Yamauchi, M., Banes, A. J., & Koller, B. H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00339.2005 · Cited by 69
Cited by
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
Oxidative Stress in Neurodegenerative Diseases
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800
Aborode, A. T., Pustake, M., Awuah, W. A., Alwerdani, M., Shah, P., Yarlagadda, R., Ahmad, S., Silva Correia, I. F., Chandra, A., Nansubuga, E. P., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7934442 · Cited by 124
Abnormal vibrissa‐related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics
Flanigan, T. J., Xue, Y., Kishan Rao, S., Dhanushkodi, A., & McDonald, M. P. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12133 · Cited by 104
Self-citationHarrison, F. E., Dawes, S. M., Meredith, M. E., Babaev, V. R., Li, L., & May, J. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.008 · Cited by 94
“MDA was measured as previously described [17].”
Metadata
- Authors
- Harrison, F. E., May, J. M., & McDonald, M. P.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 94
- Issue
- 4
- Pages
- 543-552
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2018664741
- Cited by
- 34
- References
- 23
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.